-
Irritable bowel syndrome is concentrated in people with higher educations in Iran: an inequality analysis
-
Asieh Mansouri
 , Mostafa Amini Rarani, Mosayeb Fallahi, Iman Alvandi
-
Epidemiol Health. 2017;39:e2017005. Published online February 1, 2017
-
DOI: https://doi.org/10.4178/epih.e2017005
-
-
13,507
View
-
270
Download
-
7
Citations
-
 Abstract
 PDF
-
Abstract
OBJECTIVES
Like any other health-related disorder, irritable bowel syndrome (IBS) has a differential distribution with respect to socioeconomic factors. This study aimed to estimate and decompose educational inequalities in the prevalence of IBS.
METHODS Sampling was performed using a multi-stage random cluster sampling approach. The data of 1,850 residents of Kish Island aged 15 years or older were included, and the determinants of IBS were identified using a generalized estimating equation regression model. The concentration index of educational inequality in cases of IBS was estimated and decomposed as the specific inequality index.
RESULTS The prevalence of IBS in this study was 21.57% (95% confidence interval [CI], 19.69 to 23.44%). The concentration index of IBS was 0.20 (95% CI, 0.14 to 0.26). A multivariable regression model revealed that age, sex, level of education, marital status, anxiety, and poor general health were significant determinants of IBS. In the decomposition analysis, level of education (89.91%), age (−11.99%), and marital status (9.11%) were the three main contributors to IBS inequality. Anxiety and poor general health were the next two contributors to IBS inequality, and were responsible for more than 12% of the total observed inequality.
CONCLUSIONS The main contributors of IBS inequality were education level, age, and marital status. Given the high percentage of anxious individuals among highly educated, young, single, and divorced people, we can conclude that all contributors to IBS inequality may be partially influenced by psychological factors. Therefore, programs that promote the development of mental health to alleviate the abovementioned inequality in this population are highly warranted.
-
Summary
Korean summary
Key Message
-
Citations
Citations to this article as recorded by  - The prevalence and risk factors of irritable bowel syndrome in Saudi Arabia in 2019
NaifH Alqahtani, MohammadEid M Mahfouz
International Journal of Preventive Medicine.2022; 13(1): 13. CrossRef - The Association between Adherence to the MIND Diet and Irritable Bowel Syndrome
Saeedeh Nouri-Majd, Asma Salari-Moghaddam, Ammar Hassanzadeh Keshteli, Ahmad Esmaillzadeh, Peyman Adibi
Digestive Diseases.2022; 40(2): 198. CrossRef - Association of Diet, Body Mass Index, and Lifestyle on the Gastrointestinal Health Risk in a Sample of Adults
Reyna Sámano, Fernanda Esparza-Juárez, Gabriela Chico-Barba, Erika González-Medina, Bernarda Sánchez-Jiménez, María Hernández-Trejo
International Journal of Environmental Research and Public Health.2022; 19(17): 10569. CrossRef - Decomposing educational inequality in maternal mortality in Iran
Mostafa Amini-Rarani, Asieh Mansouri, Mehdi Nosratabadi
Women & Health.2021; 61(3): 244. CrossRef - Irritable Bowel Syndrome Prevalence among Participants of Woodstock Rock Festival in Poland Based on Rome IV Criteria Questionnaire
Joanna Palma, Justyna Antoniewicz, Krzysztof Borecki, Karol Tejchman, Karolina Skonieczna-Żydecka, Dominika Maciejewska-Markiewicz, Karina Ryterska, Natalia Komorniak, Maja Czerwińska-Rogowska, Anna Wolska, Honorata Mruk-Mazurkiewicz, Anna Gudan, Tomasz M
International Journal of Environmental Research and Public Health.2021; 18(21): 11464. CrossRef - The prevalence of irritable bowel syndrome among Saudi population in Riyadh by use of Rome IV criteria and self-reported dietary restriction
HusseinS Amin, Farhana Irfan, SyedI Karim, SaifM Almeshari, KhaledA Aldosari, AbdullahM Alzahrani, AdnanT Almogbel, SaadM Alfouzan, AnasA Alsaif
Saudi Journal of Gastroenterology.2021; 27(6): 383. CrossRef - Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Vahid Zamani
Alimentary Pharmacology & Therapeutics.2019; 50(2): 132. CrossRef
|
KSE
